Mary Anne Dunkin, Contributing Writer

Feature Story

Topical JAK Inhibitor Offers Promise for Two Skin Diseases

09/15/2021

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies...

09/15/2021

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Mary Anne Dunkin, Contributing Writer

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products